A 32-year-old woman presents to the clinic with a 6-month history of progressive exertional dyspnea and fatigue. She has no history of smoking, asthma, or illicit drug use, and takes no medications. Physical examination reveals a prominent right ventricular heave, a loud pulmonic component of the second heart sound (), and trace bilateral lower extremity edema. The lungs are clear to auscultation. Electrocardiography demonstrates right axis deviation and right ventricular hypertrophy. Arrange the following steps in the most appropriate sequential order for the comprehensive diagnostic evaluation and initial management of this patient's suspected condition.
- 1Perform transthoracic echocardiography
- 2Obtain a radionuclide ventilation-perfusion (V/Q) scan
- 3Perform right heart catheterization
- 4Conduct acute pulmonary vasoreactivity testing
- 5Initiate targeted pharmacotherapy based on hemodynamic response
Answer
The correct sequence is: Transthoracic echocardiography → Ventilation-perfusion (V/Q) scan → Right heart catheterization → Acute pulmonary vasoreactivity testing → Initiation of targeted pharmacotherapy.
In a young patient presenting with signs of right heart failure (right ventricular heave, prominent P2, edema) without a history of left heart disease or chronic lung disease, pulmonary arterial hypertension (WHO Group 1) is highly suspected. The established clinical guideline algorithm dictates that evaluation must begin with non-invasive screening via transthoracic echocardiography to estimate pressures. If pulmonary hypertension is likely, secondary causes must be evaluated non-invasively; notably, a V/Q scan is the modality of choice to screen for CTEPH (WHO Group 4). Only after non-invasive evaluation suggests PAH should the patient undergo right heart catheterization, which is the gold standard for definitive diagnosis. During the catheterization, acute vasoreactivity testing (using inhaled nitric oxide, epoprostenol, or adenosine) must be performed. Finally, the results of the vasoreactivity test dictate the choice of targeted pharmacotherapy.
Step-by-Step Solution
Key Concept
The diagnostic algorithm for pulmonary hypertension progresses strictly from non-invasive screening (echocardiography) to etiology identification (V/Q scan, PFTs), followed by definitive invasive confirmation (right heart catheterization) with concurrent vasoreactivity testing to guide targeted medical therapy.